Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Rationale for Selective Laser Trabeculoplasty in Africa

The Rationale for Selective Laser Trabeculoplasty in Africa Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 REVIEW ARTICLE Tony Realini, MD, MPH,* Olusola Olawoye, MD,† Nkiru Kizor-Akaraiwe, MD,‡ Selina Manji, MSc, PharmD,§ and Arthur Sit, SM, MD¶ people in other regions to be blinded by the disease. Abstract: Glaucoma is the leading cause of irreversible blindness in The high prevalence of glaucoma in Africa can be explained Africa. The condition is treatable but not curable. There are numerous 4 largely by genetics, as described by Allingham in the 2017 obstacles to glaucoma care in Africa, including availability, accessibil- American Glaucoma Society’s Clinician-Scientist Lecture. The ity and affordability of treatments, as well as medication nonadherence high prevalence of glaucoma blindness is likely attributable to among patients. Medical therapy is costly relative to the average in- the numerous barriers to treatment in Africa and other developing come in Africa and it requires daily self-dosing by patients. Surgery is countries. The most important of these are limitations in avail- of limited availability in many regions in Africa, and a high proportion ability, affordability and acceptability of treatments, along with of patients refuse surgery because it is expensive. Selective laser trabecu- 5,6 a widespread lack of awareness of the disease itself. Because http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

Loading next page...
 
/lp/wolters-kluwer-health/the-rationale-for-selective-laser-trabeculoplasty-in-africa-nNZGvMHfuu
Publisher
Wolters Kluwer Health
ISSN
2162-0989
eISSN
2475-5028
DOI
10.22608/APO.2018271
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 REVIEW ARTICLE Tony Realini, MD, MPH,* Olusola Olawoye, MD,† Nkiru Kizor-Akaraiwe, MD,‡ Selina Manji, MSc, PharmD,§ and Arthur Sit, SM, MD¶ people in other regions to be blinded by the disease. Abstract: Glaucoma is the leading cause of irreversible blindness in The high prevalence of glaucoma in Africa can be explained Africa. The condition is treatable but not curable. There are numerous 4 largely by genetics, as described by Allingham in the 2017 obstacles to glaucoma care in Africa, including availability, accessibil- American Glaucoma Society’s Clinician-Scientist Lecture. The ity and affordability of treatments, as well as medication nonadherence high prevalence of glaucoma blindness is likely attributable to among patients. Medical therapy is costly relative to the average in- the numerous barriers to treatment in Africa and other developing come in Africa and it requires daily self-dosing by patients. Surgery is countries. The most important of these are limitations in avail- of limited availability in many regions in Africa, and a high proportion ability, affordability and acceptability of treatments, along with of patients refuse surgery because it is expensive. Selective laser trabecu- 5,6 a widespread lack of awareness of the disease itself. Because

Journal

The Asia-Pacific Journal of OphthalmologyWolters Kluwer Health

Published: Nov 1, 2018

There are no references for this article.